The Value of Follow-Up Liver Stiffness Changes Measured by Virtual Touch Quantification Elastography for Predicting Recurrence of Gastroesophageal Varices after Endoscopic Injection Sclerotherapy on Cirrhotic Patients
Table 3
Results of the univariate and multivariate analyses based on the training cohort.
Characteristic
Univariate analysis
Multivariate analysis
OR (95% CI)
OR (95% CI)
Age, years
0.986 (0.948-1.025)
0.477
/
/
Gender
0.714 (0.282-1.811)
0.478
/
/
BMI
0.970 (0.809-1.163)
0.743
/
/
Etiology
0.996 (0.991-1.000)
0.035
/
/
MELD
0.873 (0.648-1.177)
0.375
/
/
Sarin type
0.795 (0.311-2.034)
0.633
/
/
Severity of GEV
0.834 (0.649-1.679)
0.951
/
/
Red sigh
0.365 (0.066-2.018)
0.248
/
/
Portal vein thrombosis
1.144 (0.414-3.164)
0.795
/
/
Ascites
1.818 (0.691-4.782)
0.226
/
/
ALB (IU/mL)
1.223 (1.050-1.424)
0.246
/
/
TB (IU/mL)
0.993 (0.971-1.017)
0.573
/
/
ALT (IU/mL)
1.024 (0.984-1.066)
0.245
/
/
AST (IU/mL)
1.308 (0.894-0.997)
0.437
/
/
ALP (IU/mL)
1.012 (1.000-1.025)
0.053
/
/
GGT (IU/mL)
1.019 (1.001-1.037)
0.133
/
/
Creatinine (IU/mL)
1.004 (0.972-1.036)
0.831
/
/
PLT (×103/μL)
1.002 (0.995-1.009)
0.608
/
/
INR
1.364 (0.530-0.980)
0.106
/
/
Post beta-blockers
1.104 (0.643-0.870)
0.231
/
/
ΔLS 5
1.389 (1.058-1.825)
0.018
0.811 (0.542-1.211)
0.306
ΔLS 6
1.589 (1.234-2.045)
0.001
1.837 (1.243-2.715)
0.002
ALB: albumin; ALP: alkaline phosphatase; PLT: blood platelet; ALT: alanine aminotransferase; AST; aspartate aminotransferase; TB: serum total bilirubin; GGT: glutamyl transpeptidase; GLOB: globulin; PT: prothrombin time; INR: international normalized ratio; ALP: alkaline phosphatase; RBC: red blood cell; OR: odds ratio; 95% CI: 95% confidence intervals; ΔLS 5: the day of discharge and 4 months after discharge; ΔLS 6: the day of discharge and 6 months after discharge. value < 0.05.
